Deals & Capital Markets
Merck Emerges as Lead Suitor for Revolution Medicines at $28-32 Billion
5d ago
You're signed outSign in or to get full access.
Leadership at Merck & Co.
Browse executives, board members, and key leadership.
Executives at Merck & Co.
Robert M. Davis
Chief Executive Officer and President
CEO
Executive
Board
Betty Larson
Executive Vice President and Chief Human Resources Officer
Executive
Caroline Litchfield
Executive Vice President and Chief Financial Officer
Executive
Dean Li
Executive Vice President and President, Merck Research Laboratories
Executive
Richard R. DeLuca, Jr.
Executive Vice President and President, Merck Animal Health
Executive
Board Members at Merck & Co.
Christine E. Seidman, M.D.
Director
Board
Douglas M. Baker, Jr.
Director
Board
Inge G. Thulin
Director
Board
Kathy J. Warden
Director
Board
Mary Ellen Coe
Director
Board
Pamela J. Craig
Director
Board
Patricia F. Russo
Director
Board
Paul B. Rothman, M.D.
Director
Board
Risa J. Lavizzo-Mourey, M.D.
Director
Board
Stephen L. Mayo, Ph.D.
Director
Board
Surendralal L. Karsanbhai
Director
Board
Thomas H. Glocer
Lead Independent Director
Board
